TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU).

Jonathan E Rosenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.